No registrations found.
ID
Source
Brief title
Health condition
Asthma
Sponsors and support
Intervention
Outcome measures
Primary outcome
The recordings of the focus groups and interviews will be transcribed, coded and analyzed according to the consolidated criteria for reporting qualitative research (COREQ). The results will be used to formulate an implementation plan for smart inhalers into the Dutch healthcare system.
Secondary outcome
N/A
Background summary
Smart inhalers are promising in increasing medication adherence in asthma patients and maintaining asthma control. Yet, no smart inhaler has been successfully implemented in the Dutch healthcare system. In this qualitative study, we aim to explore the perspectives of stakeholders regarding smart inhalers and their implementation into the Dutch healthcare system. We will conduct focus groups with asthma patients and health care professionals. Furthermore, we will conduct interviews with regulators.
Study objective
The results will give insight into stakeholders’ opinions and motivation in relation to the smart inhalers and their implementation.
Study design
The focus groups and the interviews will take place between April and June 2020.
Intervention
2 focus groups (one with health care professionals and one with patients) and several interviews with regulators will be conducted.
Inclusion criteria
Inclusion criteria patients:
- Age ≥ 18 years
- Self-reported doctor-diagnosed asthma
- Use of maintenance inhalation medication for asthma
- Adequate oral fluency in Dutch
- Willing and able to provide written informed consent
Exclusion criteria
Exclusion criteria patients: Asthma patients only using quick-relief (rescue) medication
Design
Recruitment
IPD sharing statement
Plan description
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL8495 |
| Other | METc UMCG : METc 2020/145, UMCG 202000177 |